Elisabetta Cariani

Summary

Publications

  1. ncbi request reprint Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response
    E Cariani
    III Laboratory, Hospital of Brescia, p le Spedali Civili 1, 25123, Brescia, Italy
    Ann Hematol 82:333-5. 2003
  2. doi request reprint Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C
    Elisabetta Cariani
    Clinical Pathology Toxicology, Ospedale Civile S Agostino Estense, Modena, Italy
    J Virol Methods 178:235-8. 2011
  3. doi request reprint Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection
    Elisabetta Cariani
    Clinical Pathology Toxicology, Ospedale Civile S Agostino Estense, Modena, Italy
    Clin Chem Lab Med 49:1247-56. 2011
  4. ncbi request reprint Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays
    Elisabetta Cariani
    Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, A O Spedali Civili, Brescia, Italy
    J Hepatol 46:743-7. 2007
  5. pmc Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
    Elisabetta Cariani
    Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, and A O Spedali Civili, Brescia, Italy
    BMC Infect Dis 7:138. 2007
  6. ncbi request reprint Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies
    Anna Maria Pelizzari
    UO Ematologia, Spedali Civili, Brescia, Italy
    Hematol J 5:325-8. 2004
  7. pmc Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma
    Francesca Perandin
    Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, Brescia, Italy
    BMC Microbiol 7:22. 2007
  8. ncbi request reprint Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma
    Isabella Zanella
    Institute of Chemistry, School of Medicine, University of Brescia, Brescia, Italy
    J Med Virol 68:494-9. 2002
  9. pmc Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma
    Elisabetta Cariani
    Clinical Pathology Toxicology, Ospedale S Agostino Estense, Modena, Italy
    PLoS ONE 7:e32493. 2012
  10. doi request reprint Effectiveness of the biological monitoring of chemical exposure in the workplace: results of a survey in an area of Northern Italy
    Rudy Ivan Paredes Alpaca
    Workplace Prevention and Safety Service SPSAL, South Area, Azienda Unità Sanitaria Locale Modena, Modena, Italy
    Int J Hyg Environ Health 214:121-6. 2011

Collaborators

  • Erica Villa
  • Francesca Perandin
  • Giuseppe Rossi
  • Enrico Maria Silini
  • Carlo Ferrari
  • Gabriele Missale
  • Luisa Imberti
  • Franco Gargiulo
  • Rudy Ivan Paredes Alpaca
  • Simona Urbani
  • Anna Ludovica Fracanzani
  • Anna Maria Pelizzari
  • Angelo Rossini
  • Isabella Zanella
  • Renato Di Rico
  • Arcangelo Migliore
  • Claudia Canali
  • Cristina Rota
  • Tommaso Trenti
  • Cristina Bertelli
  • Silvia Fargion
  • Angelo Sangiovanni
  • Pietro Amoroso
  • Maria Antonietta Stazi
  • Barbara Amadei
  • Paola Fisicaro
  • Alessandra Orlandini
  • Maurizio Tommasini
  • Sonia Brescianini
  • Erika Fatta
  • Valeria Patriarca
  • Luca Valenti
  • Tomaso Stroffolini
  • Maddalena Motta
  • Erika Borlenghi
  • Paola Turconi
  • Alberto Albertini
  • Daniela Domenighini

Detail Information

Publications12

  1. ncbi request reprint Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response
    E Cariani
    III Laboratory, Hospital of Brescia, p le Spedali Civili 1, 25123, Brescia, Italy
    Ann Hematol 82:333-5. 2003
    ..These results suggest that bcr/abl mRNA levels may reflect cytogenetic response only during the early phases of imatinib therapy...
  2. doi request reprint Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C
    Elisabetta Cariani
    Clinical Pathology Toxicology, Ospedale Civile S Agostino Estense, Modena, Italy
    J Virol Methods 178:235-8. 2011
    ..85%; p=0.015). These results indicate that the possibility of reliable IL28B genotyping using different DNA sources may represent a useful tool for both clinical research and characterization of patients with hepatitis C...
  3. doi request reprint Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection
    Elisabetta Cariani
    Clinical Pathology Toxicology, Ospedale Civile S Agostino Estense, Modena, Italy
    Clin Chem Lab Med 49:1247-56. 2011
    ..This review will cover recent reports on the subject, focusing on the potential use of the new genetic markers in the diagnostic algorithm for the stratification of patients for personalized antiviral regimens...
  4. ncbi request reprint Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays
    Elisabetta Cariani
    Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, A O Spedali Civili, Brescia, Italy
    J Hepatol 46:743-7. 2007
    ..HBV DNA determination may be necessary to exclude mutant HBV as a cause of HAA, particularly in categories at high risk of mutant selection such as agammaglobulinemic and transplanted patients...
  5. pmc Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
    Elisabetta Cariani
    Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, and A O Spedali Civili, Brescia, Italy
    BMC Infect Dis 7:138. 2007
    ..The aim of this study was to analyse the relationship between HCMV DNA and pp65 antigenemia levels in order to identify clinically useful threshold values for the management of patients...
  6. ncbi request reprint Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies
    Anna Maria Pelizzari
    UO Ematologia, Spedali Civili, Brescia, Italy
    Hematol J 5:325-8. 2004
    ..In conclusion, among HBV carriers treated with chemotherapy for haematologic malignancies, the emergence of HBV YMMD mutant occurred in 3.1% of prophylactic lamivudine courses and was of little clinical relevance...
  7. pmc Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma
    Francesca Perandin
    Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, Brescia, Italy
    BMC Microbiol 7:22. 2007
    ..The aim of this study is to compare the performance of two real-time PCR assays for EBV DNA: a commercial kit as the Q-EBV Real-Time System (Q-EBV PCR, Amplimedical, Turin, Italy) and an in-house assay (EBV RQ-PCR)...
  8. ncbi request reprint Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma
    Isabella Zanella
    Institute of Chemistry, School of Medicine, University of Brescia, Brescia, Italy
    J Med Virol 68:494-9. 2002
    ..001). These results show that the quantitation of liver HBV DNA by real-time PCR can be useful to understand HBV state in hepatocellular carcinoma and viral interplay in patients with multiple viral infections...
  9. pmc Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma
    Elisabetta Cariani
    Clinical Pathology Toxicology, Ospedale S Agostino Estense, Modena, Italy
    PLoS ONE 7:e32493. 2012
    ..HCC infiltrate is characterized by the expression of molecules with negative regulatory function that may favor tumor recurrence and poor survival...
  10. doi request reprint Effectiveness of the biological monitoring of chemical exposure in the workplace: results of a survey in an area of Northern Italy
    Rudy Ivan Paredes Alpaca
    Workplace Prevention and Safety Service SPSAL, South Area, Azienda Unità Sanitaria Locale Modena, Modena, Italy
    Int J Hyg Environ Health 214:121-6. 2011
    ....
  11. ncbi request reprint The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection
    Simona Urbani
    Laboratory of Viral Immunopathology, Department of Infectious Diseases and Hepatology, Azienda Ospedaliera di Parma, Parma, Italy
    J Immunol 175:7519-29. 2005
    ....
  12. ncbi request reprint Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma
    Anna Ludovica Fracanzani
    Dipartimento Medicina Interna, Ospedale Maggiore IRCCS, Via F Sforza 35, 20122 Milano, Italy
    Blood Cells Mol Dis 35:27-32. 2005
    ....